Sirtuins in Glaucomatous Optic Neuropathy

Sirtuins 在青光眼视神经病变中的作用

基本信息

  • 批准号:
    8389546
  • 负责人:
  • 金额:
    $ 59.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT This proposal addresses the idea that activation of sirtuin-1 (Sirt1), a deacetylase that can regulate gene expression, will increase retinal ganglion cell (RGC) survival and visual system function in glaucoma. Activation of Sirt1 is essential to caloric restriction-induced reduction of age-related morbidity and increase of lifespan. This enzyme exerts its effects on metabolism, mitochondrial function, and other cell functions largely by deacetylation of histones and other proteins. Caloric restriction-induced protection against the normal age-related loss of retinal ganglion cells by Sirt1 activation suggests that the sirtuins are highly relevant to glaucoma. Growing evidence indicates that many, though not all, of the salutary benefits of caloric restriction can be induced by feeding with resveratrol, a sirtuin activator and natural compound, that is enriched in certain foods including red wine and peanuts. Our overall hypothesis is that increased Sirt1 activation will protect against glaucomatous damage in the retina, optic nerve, and brain of mouse models of glaucoma. Our general approach will be to investigate the effect of increasing Sirt1 activation by caloric restriction or by dietary resveratrol supplementation and to identify the role of Sirt1 by the use of transgenic mice lacking SIRT1 expression in their RGCs. Specific Aims will be: 1) to determine whether Sirt1 activation will reduce RGC loss of Thy-1 gene expression and RGC death following optic nerve injury; 2) to determine the biological basis of Sirt1-mediated RGC protection by evaluating retinal lipid peroxidation, mitochondrial integrity and function, and acetylation of proteins (including histones and transcription factors) critically involved in gene regulation; and 3) to determine whether Sirt1 activation preserves the structural integrity and function of the central visual system pathway.
摘要 这项提议提出了这样的想法,即激活sirtuin-1(Sirt 1),一种脱乙酰酶,可以调节 基因表达,将增加视网膜神经节细胞(RGC)的存活和视觉系统功能 青光眼Sirt 1的激活对热量限制诱导的年龄相关性降低至关重要。 发病率和寿命延长。这种酶对新陈代谢、线粒体 功能,以及其他细胞功能主要通过组蛋白和其他蛋白质的脱乙酰化来实现。热量 Sirt 1对视网膜神经节细胞正常年龄相关损失的限制性保护作用 激活表明sirtuins与青光眼高度相关。越来越多的证据表明 尽管不是全部,但许多热量限制的有益效果可以通过喂食来诱导 白藜芦醇,一种sirtuin激活剂和天然化合物,富含某些食物,包括 红酒和花生我们的总体假设是,增加Sirt 1激活将保护 青光眼小鼠模型的视网膜、视神经和脑的青光眼性损害。我们 一般的方法将是研究通过热量限制增加Sirt 1激活的效果 或通过膳食白藜芦醇补充剂,并通过使用转基因技术鉴定Sirt 1的作用。 在RGCs中缺乏SIRT 1表达的小鼠。具体目标是:1)确定Sirt 1是否 激活将减少RGC的Thy-1基因表达损失和视神经损伤后RGC的死亡。 2)通过评估视网膜损伤,确定Sirt 1介导的RGC保护的生物学基础。 脂质过氧化、线粒体完整性和功能以及蛋白质(包括 组蛋白和转录因子)关键参与基因调控;和3)以确定是否 Sirt 1的激活保留了中枢视觉系统通路的结构完整性和功能。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush.
溴莫尼定可防止视神经挤压后 Thy-1 启动子激活丧失
  • DOI:
    10.1186/1471-2415-13-26
  • 发表时间:
    2013-06-27
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Dai Y;Lindsey JD;Duong-Polk KX;Chindasub P;Leung CK;Weinreb RN
  • 通讯作者:
    Weinreb RN
Protection by an oral disubstituted hydroxylamine derivative against loss of retinal ganglion cell differentiation following optic nerve crush.
  • DOI:
    10.1371/journal.pone.0065966
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Lindsey JD;Duong-Polk KX;Dai Y;Nguyen DH;Leung CK;Weinreb RN
  • 通讯作者:
    Weinreb RN
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT N WEINREB其他文献

ROBERT N WEINREB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT N WEINREB', 18)}}的其他基金

Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
光学相干断层扫描血管造影对青光眼的诊断和监测
  • 批准号:
    10615796
  • 财政年份:
    2018
  • 资助金额:
    $ 59.6万
  • 项目类别:
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
光学相干断层扫描血管造影对青光眼的诊断和监测
  • 批准号:
    10444613
  • 财政年份:
    2018
  • 资助金额:
    $ 59.6万
  • 项目类别:
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
光学相干断层扫描血管造影对青光眼的诊断和监测
  • 批准号:
    9921397
  • 财政年份:
    2018
  • 资助金额:
    $ 59.6万
  • 项目类别:
Ophthalmology and Visual Sciences Career Development K12 Program
眼科和视觉科学职业发展 K12 计划
  • 批准号:
    8847895
  • 财政年份:
    2015
  • 资助金额:
    $ 59.6万
  • 项目类别:
Ophthalmology and Visual Sciences Career Development K12 Program
眼科和视觉科学职业发展 K12 计划
  • 批准号:
    9254555
  • 财政年份:
    2015
  • 资助金额:
    $ 59.6万
  • 项目类别:
Ophthalmology and Visual Sciences Career Development K12 Program
眼科和视觉科学职业发展 K12 计划
  • 批准号:
    10450760
  • 财政年份:
    2015
  • 资助金额:
    $ 59.6万
  • 项目类别:
Ophthalmology and Visual Sciences Career Development K12 Program
眼科和视觉科学职业发展 K12 计划
  • 批准号:
    9040968
  • 财政年份:
    2015
  • 资助金额:
    $ 59.6万
  • 项目类别:
Ophthalmology and Visual Sciences Career Development K12 Program
眼科和视觉科学职业发展 K12 计划
  • 批准号:
    10676982
  • 财政年份:
    2015
  • 资助金额:
    $ 59.6万
  • 项目类别:
Ophthalmology and Visual Sciences Career Development K12 Program
眼科和视觉科学职业发展 K12 计划
  • 批准号:
    10190539
  • 财政年份:
    2015
  • 资助金额:
    $ 59.6万
  • 项目类别:
Sirtuins in Glaucomatous Optic Neuropathy
Sirtuins 在青光眼视神经病变中的作用
  • 批准号:
    8041809
  • 财政年份:
    2011
  • 资助金额:
    $ 59.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了